Preeclampsia is associated with decreased serum alpha(2)-HS glycoprotein (fetuin-A) concentration (Q47699767)

4 February 2018

title

Preeclampsia is associated with decreased serum alpha(2)-HS glycoprotein (fetuin-A) concentration (English)

1 reference

4 February 2018

0 references

1

1 reference

4 February 2018

László Kalabay

object named as

László Kalabay

2

0 references

author name string

Zoltán Derzsy

3

1 reference

4 February 2018

András Szarka

4

1 reference

4 February 2018

Amrita Halmos

5

1 reference

4 February 2018

Balázs Stenczer

6

1 reference

4 February 2018

Philippe Arnaud

7

1 reference

4 February 2018

István Karádi

8

1 reference

4 February 2018

Zoltán Prohászka

9

1 reference

4 February 2018

János Rigó

10

1 reference

4 February 2018

publication date

29 May 2009

1 reference

4 February 2018

published in

Hypertension Research

1 reference

4 February 2018

volume

32

1 reference

4 February 2018

issue

8

1 reference

4 February 2018

page(s)

665-669

1 reference

4 February 2018

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Preeclampsia: an excessive maternal inflammatory response to pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Latest advances in understanding preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Preeclampsia and the systemic inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Th1/Th2 balance in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

The role of the immune system in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Toll-like receptor 4 gene polymorphisms and preeclampsia: lack of association in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

The M235T variant of the angiotensinogen gene is related to development of self-reported hypertension during pregnancy: the Prospect-EPIC cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Alpha2-HS glycoprotein: a protein in search of a function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Serum alpha 2-HS glycoprotein concentration in patients with hematological malignancies. A follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Plasma alpha2-HS glycoprotein concentrations in patients with acute myocardial infarction quantified by a modified ELISA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Alpha 2HS-glycoprotein in the serum and urine of patients with renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Biosynthesis of oestrogens and their inter-conversion in human placentae from normal and toxaemic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Neutrophil activation and C-reactive protein concentration in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

AHSG gene variant is associated with leanness among Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Phosphorylation of human plasma alpha2-Heremans-Schmid glycoprotein (human fetuin) in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Endothelial dysfunction and fetuin A levels before and after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Arterial stiffness in preeclamptic and chronic hypertensive pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

Immunoregulation in normal pregnancy and pre-eclampsia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Opsonic properties of human serum alpha-2 hs glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Decreased serum alfa2-HS-glycoprotein concentration in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Human fetuin/alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

The synthesis of human alpha-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Changes in 40 serum proteins of post-menopausal women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Serum Fetuin-A Concentration and Endothelial Dysfunction in Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Fetuin/α2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Association of fibrinogen and C-reactive protein with severity of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.79

7 January 2021

Identifiers

DOI

10.1038/HR.2009.79

1 reference

4 February 2018

1 reference

4 February 2018